Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schwaller

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Blood|February 25, 1999
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitorM H Tomasson, I R Williams, R Hasserjian, et al.
Leukemia|January 16, 2013
Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75)H Méreau, J De Rijck, K Cermáková, et al.
British Journal of Haematology|September 1, 1995
Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemiasT Nakamaki, N Kawamata, J Schwaller, et al.
Blood|July 15, 1995
Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhoodS Takeuchi, C R Bartram, T Seriu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 26, 2001
Expression of TCL1 in hematologic disordersJ Roos, I Hennig, J Schwaller, et al.
Leukemia|December 17, 2014
Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemiaJ J Qiu, B B Zeisig, S Li, et al.
Leukemia & Lymphoma|October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemiaT Pabst, U R Peters, M Tinguely, et al.
Blood|June 5, 2001
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)J Schwaller, E Anastasiadou, D Cain, et al.
The EMBO Journal|September 16, 1998
Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genesJ Schwaller, J Frantsve, J Aster, et al.
Molecular Cell|October 13, 2000
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2J Schwaller, E Parganas, D Wang, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Blood|February 25, 1999
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitorM H Tomasson, I R Williams, R Hasserjian, et al.
Leukemia|January 16, 2013
Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75)H Méreau, J De Rijck, K Cermáková, et al.
British Journal of Haematology|September 1, 1995
Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemiasT Nakamaki, N Kawamata, J Schwaller, et al.
Blood|July 15, 1995
Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhoodS Takeuchi, C R Bartram, T Seriu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 26, 2001
Expression of TCL1 in hematologic disordersJ Roos, I Hennig, J Schwaller, et al.
Leukemia|December 17, 2014
Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemiaJ J Qiu, B B Zeisig, S Li, et al.
Leukemia & Lymphoma|October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemiaT Pabst, U R Peters, M Tinguely, et al.
Blood|June 5, 2001
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)J Schwaller, E Anastasiadou, D Cain, et al.
The EMBO Journal|September 16, 1998
Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genesJ Schwaller, J Frantsve, J Aster, et al.
Molecular Cell|October 13, 2000
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2J Schwaller, E Parganas, D Wang, et al.
Pageof 4